# Hepatic Arterial Infusion of Nab-Paclitaxel in Patients With Metastatic Melanoma in the Liver

> **NCT00833807** · PHASE1 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 30 (actual)

## Conditions studied

- Melanoma
- Liver Metastasis

## Interventions

- **DRUG:** Nab-Paclitaxel (Abraxane)

## Key facts

- **NCT ID:** NCT00833807
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2015-11-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00833807

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00833807, "Hepatic Arterial Infusion of Nab-Paclitaxel in Patients With Metastatic Melanoma in the Liver". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00833807. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*